Difference between revisions of "Bouachour"
(Imported from Wikispaces) |
|||
| Line 1: | Line 1: | ||
| − | |||
| − | <span style=" | + | <span style="line-height:normal">'''<span style="font-size:18.0pt"><span style="font-family:" times="" new="" roman",serif"="">Adjunctive hyperbaric oxygen improved the rate of healing and reduced requirements for re-operation in crush injuries of the limbs.</span></span>'''</span> |
| − | |||
| − | <span style="font-family: | ||
| − | |||
| − | |||
| − | |||
| − | + | <span style="line-height:normal">'''<span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">Clinical Bottom Line:</span></span>'''</span> | |
| − | |||
| − | |||
| − | + | <span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">1. Hyperbaric oxygen patients had an improved rate of healing.</span></span></span> | |
| − | <span style=" | ||
| − | <span style="font-family: | ||
| − | |||
| − | <span | ||
| − | + | <span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:" times="" new="" roman",serif"="">2. Fewer hyperbaric patients needed re-operation</span></span></span> | |
| − | + | ||
| − | + | ---- | |
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Citations:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">1. Bouachour G, Cronier P, Gouello J, Toulemonde J, Talha A, Alquier P. Hyperbaric oxygen therapy in the management of crush injuries: a randomised double-blind placebo-controlled clinical trial. The Journal of Trauma, Injury, Infection and Critical Care 1996; 41:333-339.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Clinical Scenario:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">40 year old patient presented with a crush injury to the leg following a motor bike crash. We wondered if hyperbaric oxygen would be of benefit.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Three-part Question:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">In patients with crush injuries of the limbs, does the adjunctive use of hyperbaric oxygen compared with standard treatment alone, result in any important improvements in healing or lower rates of re-operation?</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Search Terms:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Crush syndrome, extremities/*injuries</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">The Study:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Double-blinded concealed randomised controlled trial with intention-to-treat. Moderate or severe crush injury to one or more limbs and no contraindication to hyperbaric therapy.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Control group (N = 18; 18 analysed):</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Standard care plus sham hyperbaric oxygen twice daily for 6 days as for HBO group.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Experimental group (N = 18; 18 analysed):</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">As above, plus 100% oxygen at 2.4ATA for 90 minutes twice daily for 6 days.</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">The Evidence:</span></span>'''</span> | ||
| + | |||
| + | {| class="Table" style="border:solid windowtext 1.0pt" | ||
|- | |- | ||
| − | | '''<span style | + | | style="width:82.6pt; border:solid windowtext 1.0pt" width="113" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Outcome</span></span>'''</span></p> |
| + | | style="width:49.2pt; border:solid windowtext 1.0pt" width="68" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Time to Outcome</span></span>'''</span></p> | ||
| + | | style="width:39.9pt; border:solid windowtext 1.0pt" width="55" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Air group</span></span>'''</span></p> | ||
| + | | style="width:48.1pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">HBO group</span></span>'''</span></p> | ||
| + | | style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Relative risk reduction</span></span>'''</span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Absolute risk reduction</span></span>'''</span></p> | ||
| + | | style="width:66.05pt; border:solid windowtext 1.0pt" width="91" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:11.5pt"><span style="font-family:" times="" new="" roman",serif"="">NNT</span></span>'''</span></p> | ||
|- | |- | ||
| − | | '''<span style | + | | rowspan="2" style="width:82.6pt; border:solid windowtext 1.0pt" width="113" | |
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Wound not healed</span></span>'''</span> | ||
| + | |||
| + | | style="width:49.2pt; border:solid windowtext 1.0pt" width="68" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">60 days</span></span></span></p> | ||
| + | | style="width:39.9pt; border:solid windowtext 1.0pt" width="55" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.44</span></span></span></p> | ||
| + | | style="width:48.1pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.06</span></span></span></p> | ||
| + | | style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">86%</span></span></span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.38</span></span></span></p> | ||
| + | | rowspan="2" style="width:66.05pt; border:solid windowtext 1.0pt" width="91" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:11.5pt"><span style="font-family:" times="" new="" roman",serif"="">3</span></span></span></p> <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:11.5pt"><span style="font-family:" times="" new="" roman",serif"="">2 to 8</span></span></span></p> | ||
|- | |- | ||
| − | | | + | | colspan="3" style="width:140.2pt; border:solid windowtext 1.0pt" width="189" | <p align="right" style="margin-bottom:.0001pt; text-align:right; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">95% CI:</span></span></span></p> |
| + | | style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">29% to 100%</span></span></span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.13 to 0.64</span></span></span></p> | ||
|- | |- | ||
| − | | '''<span style | + | | rowspan="2" style="width:82.6pt; border:solid windowtext 1.0pt" width="113" | |
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Repeat surgical procedure</span></span>'''</span> | ||
| + | |||
| + | | style="width:49.2pt; border:solid windowtext 1.0pt" width="68" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">60 days</span></span></span></p> | ||
| + | | style="width:39.9pt; border:solid windowtext 1.0pt" width="55" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.33</span></span></span></p> | ||
| + | | style="width:48.1pt; border:solid windowtext 1.0pt" width="66" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.06</span></span></span></p> | ||
| + | | style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">82%</span></span></span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.27</span></span></span></p> | ||
| + | | rowspan="2" style="width:66.05pt; border:solid windowtext 1.0pt" width="91" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:11.5pt"><span style="font-family:" times="" new="" roman",serif"="">4</span></span></span></p> <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:11.5pt"><span style="font-family:" times="" new="" roman",serif"="">2 to 34</span></span></span></p> | ||
|- | |- | ||
| + | | colspan="3" style="width:140.2pt; border:solid windowtext 1.0pt" width="189" | <p align="right" style="margin-bottom:.0001pt; text-align:right; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">95% CI:</span></span></span></p> | ||
| + | | style="width:76.5pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">9% to 100%</span></span></span></p> | ||
| + | | style="width:76.45pt; border:solid windowtext 1.0pt" width="104" | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">0.03 to 0.52</span></span></span></p> | ||
|} | |} | ||
| − | + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Comments:</span></span>'''</span> | |
| − | # <span style="font-family: | + | |
| − | # <span style="font-family: ' | + | #<span style="line-height:normal"><span style="tab-stops:list 36.0pt"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Well organised and methodologically sound trial.</span></span></span></span> |
| + | #<span style="line-height:normal"><span style="tab-stops:list 36.0pt"><span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Reductions in morbidity appear clinically important</span></span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Appraised by:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Abigail Fynn, Mike Bennett, Dept. of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney; Tuesday, 30 March 1999</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">Expiry date:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:" times="" new="" roman",serif"="">November 2022</span></span></span> | ||
| + | |||
| + | | ||
| − | + | <span style="display: block; text-align: center;">[[File:Sumhorsa.gif|center|sumhorsa.gif]]</span> | |
| − | |||
| − | |||
| − | <span style="display: block; text-align: center;" | + | == <span style="color: #7c00ff; display: block; text-align: center;"><span style="font-size:xx-large;">[[Crush_injuries|BACK]]</span></span> == |
| − | |||
| − | [[ | ||
| − | + | | |
| − | |||
Revision as of 04:28, 27 September 2021
Adjunctive hyperbaric oxygen improved the rate of healing and reduced requirements for re-operation in crush injuries of the limbs.
Clinical Bottom Line:
1. Hyperbaric oxygen patients had an improved rate of healing.
2. Fewer hyperbaric patients needed re-operation
Citations:1. Bouachour G, Cronier P, Gouello J, Toulemonde J, Talha A, Alquier P. Hyperbaric oxygen therapy in the management of crush injuries: a randomised double-blind placebo-controlled clinical trial. The Journal of Trauma, Injury, Infection and Critical Care 1996; 41:333-339.
Clinical Scenario:40 year old patient presented with a crush injury to the leg following a motor bike crash. We wondered if hyperbaric oxygen would be of benefit.
Three-part Question:In patients with crush injuries of the limbs, does the adjunctive use of hyperbaric oxygen compared with standard treatment alone, result in any important improvements in healing or lower rates of re-operation?
Search Terms:Crush syndrome, extremities/*injuries
The Study:Double-blinded concealed randomised controlled trial with intention-to-treat. Moderate or severe crush injury to one or more limbs and no contraindication to hyperbaric therapy.
Control group (N = 18; 18 analysed):Standard care plus sham hyperbaric oxygen twice daily for 6 days as for HBO group.
Experimental group (N = 18; 18 analysed):As above, plus 100% oxygen at 2.4ATA for 90 minutes twice daily for 6 days.
The Evidence:
Outcome |
Time to Outcome |
Air group |
HBO group |
Relative risk reduction |
Absolute risk reduction |
NNT |
|
Wound not healed |
60 days |
0.44 |
0.06 |
86% |
0.38 |
3 2 to 8 |
95% CI: |
29% to 100% |
0.13 to 0.64 | ||||
|
Repeat surgical procedure |
60 days |
0.33 |
0.06 |
82% |
0.27 |
4 2 to 34 |
95% CI: |
9% to 100% |
0.03 to 0.52 | ||||
Comments:
- Well organised and methodologically sound trial.
- Reductions in morbidity appear clinically important
Appraised by:Abigail Fynn, Mike Bennett, Dept. of Diving and Hyperbaric Medicine, Prince of Wales Hospital, Sydney; Tuesday, 30 March 1999
Expiry date:November 2022
BACK